# Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation

> **NCT02082457** · PHASE2 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 273 (actual)

## Conditions studied

- Irritable Bowel Syndrome
- Constipation

## Interventions

- **DRUG:** YKP10811 5mg
- **DRUG:** YKP10811 20mg
- **DRUG:** YKP10811 placebo

## Key facts

- **NCT ID:** NCT02082457
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 273 (ACTUAL)
- **Last updated:** 2015-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02082457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02082457, "Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02082457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*